President Trump’s tax cuts are having a ripple effect across the markets as multinational companies like Apple pass the savings on to shareholders via increased dividends or stock buybacks. The same will be true for Big Pharma. But instead of buying back shares or raising dividends, the drug industry will go a different route—and it […]
Nick’s Note: At the Daily, we’re fans of gold… One of our favorite ways to get exposure to gold is through gold mining companies. Below, colleague Jeff Clark tells us why he thinks gold stocks are going higher over the next couple weeks… By Jeff Clark, editor, Market Minute The gold stock rally is hanging […]
Last month, Spark Therapeutics announced its newest drug would sell for $850,000—for one treatment. The name of the drug is Luxturna. And it’s the most expensive drug on the market. The Food and Drug Administration (FDA) approved Luxturna in December 2017 to treat a rare, inherited eye disease that can lead to blindness. Some consumer […]
By Nick Rokke, analyst, The Palm Beach Daily At the Daily, we don’t mind going back to the well. As long as there are profits down there, we’ll keep lowering the bucket. Today, we’re dipping back into the biotech sector. Here’s why… Juno Therapeutics is up 75% in a week Bioverativ is up 60% virtually […]
Since the start of the year, Long Blockchain’s stock is down 43%… Riot Blockchain 38%… and Chanticleer Holdings 27%. What do these three companies have in common? We told you to avoid them in the January 4 Daily. Why? Just look at the chart below. The companies are down an average of 36%. Regular readers […]
Nick’s Note: 2018 is shaping up to be the year that cryptocurrencies evolve into more than just digital money. In today’s interview, Palm Beach Confidential editor and crypto expert Teeka Tiwari says we’ll see cryptocurrencies split into two types of coins… Nick: T, last week you told me that virtual reality and artificial intelligence were […]
Nick’s Note: We’re bullish on the stock market. But that doesn’t mean we invest with blinders on. That’s why today we turn the reins over to longtime PBRG friend Bill Bonner for his contrarian view… By Bill Bonner, Chairman, Bonner & Partners It is always brightest before they turn the lights out. You can quote […]